A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: Opportunities to improve healthcare quality

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 647-651

  Raphael, Jean L ^a,b   Shetty, Priya B ^a   Liu, Hao ^a   Mahoney, Donald H ^a   Mueller, Brigitta U ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Texas Children's Hospital   (United States)

Author keywords

Pediatrics; Quality improvement; Sickle cell disease; Stroke

Indexed keywords

ARTICLE; CHILD; CHILDHOOD CANCER; DOPPLER ECHOGRAPHY; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL RECORD; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SICKLE CELL ANEMIA; STROKE; TECHNOLOGY; TERTIARY HEALTH CARE;

ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MASS SCREENING; PATIENT COMPLIANCE; QUALITY OF HEALTH CARE; SOCIOECONOMIC FACTORS; STROKE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 52249119860     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21677     Document Type: Article

References (17)

1. Prengler M, Pavlakis SG, Prohovnik I, et al. Sickle cell disease: The neurological complications. Ann Neurol 2002;51:543-552.
2. Thompson AA. Advances in the management of sickle cell disease. Pediatric Blood Cancer 2006;46:533-539.
3. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-294.
4. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998;339:5-11.
5. Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992;326:605-610.
6. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997;42:699-704.
7. Lee MT, Piomelli S, Granger S, et al., Stroke prevention trial in sickle cell anemia (STOP): Extended follow-up and final results. Blood 2006;108:847-852.
8. Berwick DM. Disseminating innovations in health care. JAMA 2003;289:1969-1975.
9. HHS. November 7, 2007. Centers for Medicare and Medicaid Services http://www.cms.hhs.gov/home/medicaid.asp. Accessed November 7, 2007.
10. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
11. Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005;129:465-481.
12. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995;36:1-10.
13. Wang W. The pathophysiology, prevention, and treatment of stroke in sickle cell disease. Curr Opin Hematol 2007;14:191-197.
14. Rogers ZR, Lieff S, McMurray M, et al. Collaborative data project (C-Data) of the Comprehensive Sickle Cell Centers Program. Blood 2006;108:207a.
15. Fullerton HJ, Gardner M, Adams RJ, et al. Obstacles to primary stroke prevention in children with sickle cell disease. Neurology 2006;67:1098-1099.
16. Patik M, Phillips L, Kladny B, et al. Structured telephone-based outreach using nonmedical personnel can improve adherence to comprehensive care in families of children with sickle cell disease. Am J Hematol 2006;81:462-464.
17. McCarville MB, Goodin GS, Fortner G, et al. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. Pediatr Blood Cancer 2008;50:818-821.